BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19772884)

  • 1. Modulation of the hepatic fatty acid pool in peroxisomal 3-ketoacyl-CoA thiolase B-null mice exposed to the selective PPARalpha agonist Wy14,643.
    Arnauld S; Fidaleo M; Clémencet MC; Chevillard G; Athias A; Gresti J; Wanders RJ; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2009; 91(11-12):1376-86. PubMed ID: 19772884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the peroxisomal 3-ketoacyl-CoA thiolase B enzyme in the control of PPARα-mediated upregulation of SREBP-2 target genes in the liver.
    Fidaleo M; Arnauld S; Clémencet MC; Chevillard G; Royer MC; De Bruycker M; Wanders RJ; Athias A; Gresti J; Clouet P; Degrace P; Kersten S; Espeel M; Latruffe N; Nicolas-Francès V; Mandard S
    Biochimie; 2011 May; 93(5):876-91. PubMed ID: 21352884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disturbances in cholesterol, bile acid and glucose metabolism in peroxisomal 3-ketoacylCoA thiolase B deficient mice fed diets containing high or low fat contents.
    Nicolas-Francès V; Arnauld S; Kaminski J; Ver Loren van Themaat E; Clémencet MC; Chamouton J; Athias A; Grober J; Gresti J; Degrace P; Lagrost L; Latruffe N; Mandard S
    Biochimie; 2014 Mar; 98():86-101. PubMed ID: 24287293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for PPARalpha in the control of SREBP activity and lipid synthesis in the liver.
    Knight BL; Hebbachi A; Hauton D; Brown AM; Wiggins D; Patel DD; Gibbons GF
    Biochem J; 2005 Jul; 389(Pt 2):413-21. PubMed ID: 15777286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted disruption of the peroxisomal thiolase B gene in mouse: a new model to study disorders related to peroxisomal lipid metabolism.
    Chevillard G; Clémencet MC; Latruffe N; Nicolas-Francès V
    Biochimie; 2004 Nov; 86(11):849-56. PubMed ID: 15589695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SCP-x gene ablation on branched-chain fatty acid metabolism.
    Atshaves BP; McIntosh AL; Landrock D; Payne HR; Mackie JT; Maeda N; Ball J; Schroeder F; Kier AB
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G939-51. PubMed ID: 17068117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism.
    Sampath H; Ntambi JM
    Curr Opin Clin Nutr Metab Care; 2006 Mar; 9(2):84-8. PubMed ID: 16477170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
    Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
    Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of stearoyl-CoA desaturase1 activates AMPK and exhibits beneficial lipid metabolic effects in vitro.
    Kim E; Lee JH; Ntambi JM; Hyun CK
    Eur J Pharmacol; 2011 Dec; 672(1-3):38-44. PubMed ID: 21970804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning, gene structure and expression profile of two mouse peroxisomal 3-ketoacyl-CoA thiolase genes.
    Chevillard G; Clémencet MC; Etienne P; Martin P; Pineau T; Latruffe N; Nicolas-Francès V
    BMC Biochem; 2004 Mar; 5():3. PubMed ID: 15043762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha).
    Aoyama T; Peters JM; Iritani N; Nakajima T; Furihata K; Hashimoto T; Gonzalez FJ
    J Biol Chem; 1998 Mar; 273(10):5678-84. PubMed ID: 9488698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
    Crabb DW; Galli A; Fischer M; You M
    Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feeding of a deep-fried fat causes PPARalpha activation in the liver of pigs as a non-proliferating species.
    Luci S; König B; Giemsa B; Huber S; Hause G; Kluge H; Stangl GI; Eder K
    Br J Nutr; 2007 May; 97(5):872-82. PubMed ID: 17381980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that the anti-obesity effect of conjugated linoleic acid is independent of effects on stearoyl-CoA desaturase1 expression and enzyme activity.
    Kang K; Miyazaki M; Ntambi JM; Pariza MW
    Biochem Biophys Res Commun; 2004 Mar; 315(3):532-7. PubMed ID: 14975733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between hepatic stearoyl-CoA desaturase-1 activity and mRNA expression with liver fat content in humans.
    Peter A; Cegan A; Wagner S; Elcnerova M; Königsrainer A; Königsrainer I; Häring HU; Schleicher ED; Stefan N
    Am J Physiol Endocrinol Metab; 2011 Feb; 300(2):E321-6. PubMed ID: 21045174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
    Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
    Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinated alteration of hepatic gene expression in fatty acid and triglyceride synthesis in LCAT-null mice is associated with altered PUFA metabolism.
    Song H; Zhu L; Picardo CM; Maguire G; Leung V; Connelly PW; Ng DS
    Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E17-E25. PubMed ID: 16105858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor alpha.
    Cheung C; Akiyama TE; Ward JM; Nicol CJ; Feigenbaum L; Vinson C; Gonzalez FJ
    Cancer Res; 2004 Jun; 64(11):3849-54. PubMed ID: 15172993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
    Ide T; Tsunoda M; Mochizuki T; Murakami K
    Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.